Phase 1 AML, Adult Clinical Trials
9 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–9 of 9 trials
Recruiting
Phase 1
Revumenib in Combination With 7+3 + Midostaurin in AML
Acute Myeloid LeukemiaAMLLeukemia+2 more
Richard Stone, MD22 enrolled2 locationsNCT06313437
Recruiting
Phase 1
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
MDSAML, Adult
Stelexis BioSciences125 enrolled13 locationsNCT06533761
Recruiting
Phase 1Phase 2
BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS
MDSAML, Adult RecurrentALL, Recurrent, Adult
BlueSphere Bio, Inc38 enrolled6 locationsNCT06704152
Recruiting
Phase 1
A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)
MDSAML, Adult Recurrent
PureTech90 enrolled9 locationsNCT05829226
Recruiting
Phase 1
A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)
AML, Adult
Zhejiang ACEA Pharmaceutical Co. Ltd.84 enrolled1 locationNCT05947344
Recruiting
Phase 1Phase 2
Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML
Acute Myeloid LeukemiaAMLAML, Adult+1 more
Essen Biotech85 enrolled1 locationNCT06420063
Recruiting
Phase 1
A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients
AML, Adult RecurrentNHL, Adult
Shengke Pharmaceuticals (Jiangsu) Limited, China60 enrolled2 locationsNCT05758610
Recruiting
Phase 1
Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia
AML, Adult
Zhejiang University24 enrolled1 locationNCT06367673
Recruiting
Phase 1
Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia
AML, Adult
Zhejiang University24 enrolled1 locationNCT06027853